2014 Q1 Form 10-Q Financial Statement
#000110465914034683 Filed on May 05, 2014
Income Statement
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| Revenue | $3.926B | $2.387B |
| YoY Change | 64.47% | 3.69% |
| Cost Of Revenue | $628.0M | $384.0M |
| YoY Change | 63.54% | -3.76% |
| Gross Profit | $3.298B | $2.003B |
| YoY Change | 64.65% | 5.25% |
| Gross Profit Margin | 84.0% | 83.91% |
| Selling, General & Admin | $1.921B | $1.203B |
| YoY Change | 59.68% | 9.46% |
| % of Gross Profit | 58.25% | 60.06% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $193.0M | $114.0M |
| YoY Change | 69.3% | 14.0% |
| % of Gross Profit | 5.85% | 5.69% |
| Operating Expenses | $3.104B | $1.843B |
| YoY Change | 68.42% | 8.86% |
| Operating Profit | $170.0M | $146.0M |
| YoY Change | 16.44% | -28.78% |
| Interest Expense | $182.0M | $103.0M |
| YoY Change | 76.7% | 5.1% |
| % of Operating Profit | 107.06% | 70.55% |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$12.00M | -$134.0M |
| YoY Change | -91.04% | -224.07% |
| Income Tax | -$1.000M | -$53.00M |
| % Of Pretax Income | ||
| Net Earnings | -$16.00M | -$83.00M |
| YoY Change | -80.72% | -223.88% |
| Net Earnings / Revenue | -0.41% | -3.48% |
| Basic Earnings Per Share | -$0.33 | -$0.85 |
| Diluted Earnings Per Share | -$0.33 | -$0.85 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 96.99M shares | 104.1M shares |
| Diluted Shares Outstanding | 104.1M shares |
Balance Sheet
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $141.0M | $95.00M |
| YoY Change | 48.42% | -8.65% |
| Cash & Equivalents | $141.0M | $95.00M |
| Short-Term Investments | ||
| Other Short-Term Assets | $839.0M | $455.0M |
| YoY Change | 84.4% | 17.88% |
| Inventory | $261.0M | $152.0M |
| Prepaid Expenses | ||
| Receivables | $2.141B | $1.383B |
| Other Receivables | $19.00M | $4.000M |
| Total Short-Term Assets | $3.978B | $2.443B |
| YoY Change | 62.83% | -1.57% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $7.723B | $4.296B |
| YoY Change | 79.77% | -0.65% |
| Goodwill | $3.070B | $948.0M |
| YoY Change | 223.84% | 28.46% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $355.0M | $163.0M |
| YoY Change | 117.79% | 6.54% |
| Other Assets | $333.0M | $479.0M |
| YoY Change | -30.48% | 40.06% |
| Total Long-Term Assets | $12.51B | $6.472B |
| YoY Change | 93.23% | 6.75% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $3.978B | $2.443B |
| Total Long-Term Assets | $12.51B | $6.472B |
| Total Assets | $16.48B | $8.915B |
| YoY Change | 84.9% | 4.33% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.019B | $625.0M |
| YoY Change | 63.04% | -2.34% |
| Accrued Expenses | $869.0M | $472.0M |
| YoY Change | 84.11% | -5.03% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $622.0M | $52.00M |
| YoY Change | 1096.15% | -81.94% |
| Total Short-Term Liabilities | $3.336B | $1.549B |
| YoY Change | 115.36% | -15.82% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $10.61B | $5.375B |
| YoY Change | 97.43% | 25.15% |
| Other Long-Term Liabilities | $453.0M | $611.0M |
| YoY Change | -25.86% | 16.16% |
| Total Long-Term Liabilities | $453.0M | $611.0M |
| YoY Change | -25.86% | 16.16% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $3.336B | $1.549B |
| Total Long-Term Liabilities | $453.0M | $611.0M |
| Total Liabilities | $15.36B | $7.833B |
| YoY Change | 96.13% | 11.93% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$1.454B | -$1.376B |
| YoY Change | 5.67% | 0.0% |
| Common Stock | $7.000M | $7.000M |
| YoY Change | 0.0% | -74.07% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $2.378B | $2.078B |
| YoY Change | 14.44% | 10.59% |
| Treasury Stock Shares | 47.20M shares | 40.17M shares |
| Shareholders Equity | $728.0M | $969.0M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $16.48B | $8.915B |
| YoY Change | 84.9% | 4.33% |
Cashflow Statement
| Concept | 2014 Q1 | 2013 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$16.00M | -$83.00M |
| YoY Change | -80.72% | -223.88% |
| Depreciation, Depletion And Amortization | $193.0M | $114.0M |
| YoY Change | 69.3% | 14.0% |
| Cash From Operating Activities | -$19.00M | -$32.00M |
| YoY Change | -40.63% | -23.81% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $281.0M | $133.0M |
| YoY Change | 111.28% | -197.79% |
| Acquisitions | $9.000M | $5.000M |
| YoY Change | 80.0% | |
| Other Investing Activities | $0.00 | -$2.000M |
| YoY Change | -100.0% | 0.0% |
| Cash From Investing Activities | -$291.0M | -$104.0M |
| YoY Change | 179.81% | -23.53% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $0.00 | $100.0M |
| YoY Change | -100.0% | 284.62% |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $338.0M | -$133.0M |
| YoY Change | -354.14% | -178.7% |
| NET CHANGE | ||
| Cash From Operating Activities | -$19.00M | -$32.00M |
| Cash From Investing Activities | -$291.0M | -$104.0M |
| Cash From Financing Activities | $338.0M | -$133.0M |
| Net Change In Cash | $28.00M | -$269.0M |
| YoY Change | -110.41% | 2888.89% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$19.00M | -$32.00M |
| Capital Expenditures | $281.0M | $133.0M |
| Free Cash Flow | -$300.0M | -$165.0M |
| YoY Change | 81.82% | -275.53% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
141000000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
113000000 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
183000000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
245000000 | USD |
| CY2014Q1 | thc |
Cash And Cash Equivalents Related To Captive Insurance Subsidiaries
CashAndCashEquivalentsRelatedToCaptiveInsuranceSubsidiaries
|
78000000 | USD |
| CY2013Q4 | thc |
Cash And Cash Equivalents Related To Captive Insurance Subsidiaries
CashAndCashEquivalentsRelatedToCaptiveInsuranceSubsidiaries
|
62000000 | USD |
| CY2013Q4 | thc |
Capital Expenditures Incurred But Not Yet Paid Current
CapitalExpendituresIncurredButNotYetPaidCurrent
|
138000000 | USD |
| CY2014Q1 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
52000000 | USD |
| CY2013 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
31000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1798000000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1715000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
569000000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
523000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1229000000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1192000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
194000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
230000000 | USD |
| CY2014Q1 | thc |
Number Of Hospitals Operated By Subsidiaries
NumberOfHospitalsOperatedBySubsidiaries
|
77 | item |
| CY2014Q1 | thc |
Number Of Licensed Beds In Hospitals Operated By Subsidiaries
NumberOfLicensedBedsInHospitalsOperatedBySubsidiaries
|
20255 | item |
| CY2014Q1 | thc |
Number Of Provider Based Out Patient Centers Operated By Subsidiaries
NumberOfProviderBasedOutPatientCentersOperatedBySubsidiaries
|
189 | item |
| CY2014Q1 | thc |
Number Of Health Plans Operated By Subsidiaries
NumberOfHealthPlansOperatedBySubsidiaries
|
6 | item |
| CY2014Q1 | thc |
Minimum Number Of Hospitals To Which Business Process Solution Is Provided By Subsidiaries
MinimumNumberOfHospitalsToWhichBusinessProcessSolutionIsProvidedBySubsidiaries
|
700 | item |
| CY2014Q1 | thc |
Health Care Organization Revenue Gross
HealthCareOrganizationRevenueGross
|
4306000000 | USD |
| CY2014Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-16000000 | USD |
| CY2013Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-83000000 | USD |
| CY2014Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
10000000 | USD |
| CY2013Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
6000000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
5000000 | USD |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
3000000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
4000000 | USD |
| CY2013Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
100000000 | USD |
| CY2014Q1 | us-gaap |
Health Care Organization Revenue
HealthCareOrganizationRevenue
|
3926000000 | USD |
| CY2014Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
113000000 | USD |
| CY2013 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
193000000 | USD |
| CY2014Q1 | thc |
Capital Expenditures Incurred But Not Yet Paid Current
CapitalExpendituresIncurredButNotYetPaidCurrent
|
60000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
152000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
122000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
94000000 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
347000000 | USD |
| CY2014Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2141000000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1965000000 | USD |
| CY2013 | thc |
Allowance For Doubtful Accounts As Percent Of Accounts Receivable
AllowanceForDoubtfulAccountsAsPercentOfAccountsReceivable
|
0.232 | pure |
| CY2014Q1 | thc |
Allowance For Doubtful Accounts As Percent Of Accounts Receivable
AllowanceForDoubtfulAccountsAsPercentOfAccountsReceivable
|
0.240 | pure |
| CY2014Q1 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
1000000 | USD |
| CY2013Q1 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
3000000 | USD |
| CY2014Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-8000000 | USD |
| CY2013Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-3000000 | USD |
| CY2013Q1 | us-gaap |
Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
|
14000000 | USD |
| CY2013Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
7000000 | USD |
| CY2013Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
2000000 | USD |
| CY2013Q1 | us-gaap |
Business Exit Costs1
BusinessExitCosts1
|
1000000 | USD |
| CY2013Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
4000000 | USD |
| CY2014Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | segment |
| CY2013Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
407000000 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
28000000 | USD |
| CY2013Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
10839000000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
149000000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
10690000000 | USD |
| CY2014Q1 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
437000000 | USD |
| CY2014Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
|
28000000 | USD |
| CY2014Q1 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
11234000000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
622000000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
10612000000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
2538611 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
2120980 | shares |
| CY2014Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P3Y10M24D | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
26.43 | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
24.96 | |
| CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
878000000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1218000000 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1046000000 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
854000000 | USD |
| CY2014Q1 | us-gaap |
Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Net Operating Revenues</font></i></b><b><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Before Provision for Doubtful Accounts</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">We recognize net operating revenues before provision for doubtful accounts in the period in which our services are performed. Net operating revenues before provision for doubtful accounts primarily consist of net patient service revenues that are recorded based on established billing rates (i.e., gross charges), less estimated discounts for contractual and other allowances, principally for patients covered by Medicare, Medicaid, managed care and other health plans, as well as certain uninsured patients under our</font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt;" size="2">Compact with Uninsured Patients</font></i> <font style="FONT-SIZE: 10pt;" size="2">(“Compact”) and other uninsured discount and charity programs</font><font style="FONT-SIZE: 10pt;" size="2">.</font></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The table below shows the sources of net operating revenues before provision for doubtful accounts:</font></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <table style="text-align:left;WIDTH: 96.66%; BORDER-COLLAPSE: collapse;" border="0" cellspacing="0" cellpadding="0" width="96%"> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"> </p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27.42%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="27%" colspan="5"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">Three Months Ended<br />  March 31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"> </p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2014</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"> </p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold;" size="1">2013</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">General Hospitals:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medicare</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">857</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.34%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.08%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">540</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Medicaid</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">292</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">188</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Managed care</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">2,190</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">1,361</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Indemnity, self-pay and other</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">447</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">260</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Acute care hospitals — other revenue</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">19</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">28</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Other:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"> </p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Other operations</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">501</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">217</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr> <tr style="padding:0;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 68.96%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="68%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Net operating revenues before provision for doubtful accounts</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.34%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">$</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">4,306</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.58%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.34%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">$</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 11.08%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="11%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">2,594</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.04%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"> </p></td></tr></table> </div> | |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
14000000 | USD |
| CY2014Q1 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
49000000 | USD |
| CY2013Q1 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
26000000 | USD |
| CY2014Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
40000000 | USD |
| CY2013Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
46000000 | USD |
| CY2012Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
10000000 | USD |
| CY2013Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
9000000 | USD |
| CY2013Q1 | us-gaap |
Loss Contingency Accrual Carrying Value Payments
LossContingencyAccrualCarryingValuePayments
|
1000000 | USD |
| CY2013Q1 | thc |
Gain Loss Total Related To Litigation Settlement
GainLossTotalRelatedToLitigationSettlement
|
0 | USD |
| CY2014Q1 | thc |
Gain Loss Total Related To Litigation Settlement
GainLossTotalRelatedToLitigationSettlement
|
-3000000 | USD |
| CY2013Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1000000 | USD |
| CY2014Q1 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
1000000 | USD |
| CY2013Q4 | us-gaap |
Alternative Investments Fair Value Disclosure
AlternativeInvestmentsFairValueDisclosure
|
2000000 | USD |
| CY2014Q1 | us-gaap |
Alternative Investments Fair Value Disclosure
AlternativeInvestmentsFairValueDisclosure
|
2000000 | USD |
| CY2013Q4 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
62000000 | USD |
| CY2014Q1 | us-gaap |
Available For Sale Securities
AvailableForSaleSecurities
|
62000000 | USD |
| CY2013Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
65000000 | USD |
| CY2014Q1 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
65000000 | USD |
| CY2014Q1 | thc |
Estimated Fair Value Of Debt Instrument As Percentage Of Carrying Value
EstimatedFairValueOfDebtInstrumentAsPercentageOfCarryingValue
|
1.054 | pure |
| CY2013Q4 | thc |
Estimated Fair Value Of Debt Instrument As Percentage Of Carrying Value
EstimatedFairValueOfDebtInstrumentAsPercentageOfCarryingValue
|
1.035 | pure |
| CY2014Q1 | thc |
Number Of Hospitals Owned By Subsidiaries
NumberOfHospitalsOwnedBySubsidiaries
|
77 | item |
| CY2014Q1 | thc |
Number Of Licensed Beds In Hospitals Operated By The Subsidiaries
NumberOfLicensedBedsInHospitalsOperatedByTheSubsidiaries
|
20255 | item |
| CY2013Q4 | us-gaap |
Assets
Assets
|
16130000000 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
16484000000 | USD |
| CY2013Q1 | thc |
Capital Expenditure
CapitalExpenditure
|
133000000 | USD |
| CY2014Q1 | thc |
Capital Expenditure
CapitalExpenditure
|
281000000 | USD |
| CY2014Q1 | thc |
Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
|
387000000 | USD |
| CY2013Q1 | thc |
Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
|
274000000 | USD |
| CY2014Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
43000000 | USD |
| CY2013Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
114000000 | USD |
| CY2014Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
193000000 | USD |
| CY2013Q1 | thc |
Restructuring Settlement Impairment Provisions And Acquisition Cost
RestructuringSettlementImpairmentProvisionsAndAcquisitionCost
|
14000000 | USD |
| CY2013Q1 | thc |
Electronic Health Record Incentives
ElectronicHealthRecordIncentives
|
0 | USD |
| CY2014Q1 | thc |
Restructuring Settlement Impairment Provisions And Acquisition Cost
RestructuringSettlementImpairmentProvisionsAndAcquisitionCost
|
21000000 | USD |
| CY2013Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
0 | USD |
| CY2014Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-3000000 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
103000000 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
182000000 | USD |
| CY2013Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-177000000 | USD |
| CY2014Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
| CY2013Q1 | thc |
Adjusted Earnings Before Income Tax
AdjustedEarningsBeforeIncomeTax
|
-134000000 | USD |
| CY2014Q1 | thc |
Adjusted Earnings Before Income Tax
AdjustedEarningsBeforeIncomeTax
|
-12000000 | USD |
| CY2014Q1 | us-gaap |
Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
|
355000000 | USD |
| CY2014Q1 | thc |
Income Tax Expense Benefit Change In Valuation Allowance Of Deferred Tax Assets
IncomeTaxExpenseBenefitChangeInValuationAllowanceOfDeferredTaxAssets
|
3000000 | USD |
| CY2014Q1 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
1000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-86000000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
104103000 | shares |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.83 | |
| CY2013Q1 | us-gaap |
Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
|
0 | USD |
| CY2013Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares |
| CY2013Q1 | thc |
Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount
EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount
|
0.00 | |
| CY2013Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-86000000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
104103000 | shares |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
170000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.83 | |
| CY2013Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
2239000 | shares |
| CY2014Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
1984000 | shares |
| CY2014Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
TENET HEALTHCARE CORP | |
| CY2014Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000070318 | |
| CY2014Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2014Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-03-31 | |
| CY2014Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2014Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
97653460 | shares |
| CY2014Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2014Q1 | us-gaap |
Inventory Net
InventoryNet
|
261000000 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
262000000 | USD |
| CY2014Q1 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
19000000 | USD |
| CY2013Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
0 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
577000000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
581000000 | USD |
| CY2014Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
839000000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
789000000 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
3978000000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3710000000 | USD |
| CY2013Q4 | us-gaap |
Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
|
405000000 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
129000000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
686000000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
262500000 | shares |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
15005000000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
719000000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
90000000 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7723000000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7691000000 | USD |
| CY2014Q1 | us-gaap |
Goodwill
Goodwill
|
3070000000 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
3042000000 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1019000000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1075000000 | USD |
| CY2014Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
595000000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
631000000 | USD |
| CY2014Q1 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
140000000 | USD |
| CY2013Q4 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
156000000 | USD |
| CY2014Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
274000000 | USD |
| CY2013Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
198000000 | USD |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3336000000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2928000000 | USD |
| CY2014Q1 | us-gaap |
Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
|
567000000 | USD |
| CY2013Q4 | us-gaap |
Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
|
543000000 | USD |
| CY2014Q1 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
395000000 | USD |
| CY2013Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
398000000 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
453000000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
446000000 | USD |
| CY2014Q1 | us-gaap |
Liabilities
Liabilities
|
15363000000 | USD |
| CY2014Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
267000000 | USD |
| CY2013Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
247000000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
7000000 | USD |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7000000 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4576000000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4572000000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-23000000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-24000000 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1454000000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1422000000 | USD |
| CY2014Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
2378000000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
2378000000 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
728000000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
755000000 | USD |
| CY2014Q1 | us-gaap |
Minority Interest
MinorityInterest
|
126000000 | USD |
| CY2013Q4 | us-gaap |
Minority Interest
MinorityInterest
|
123000000 | USD |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16484000000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16130000000 | USD |
| CY2014Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
671000000 | USD |
| CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
589000000 | USD |
| CY2014Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4018000000 | USD |
| CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3898000000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
262500000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
144782041 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
144057351 | shares |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
146000000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-12000000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-5000000 | USD |
| CY2014Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
47197211 | shares |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
47197722 | shares |
| CY2013Q1 | thc |
Health Care Organization Revenue Gross
HealthCareOrganizationRevenueGross
|
2594000000 | USD |
| CY2014Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
380000000 | USD |
| CY2013Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
207000000 | USD |
| CY2014Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1921000000 | USD |
| CY2013Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1161000000 | USD |
| CY2014Q1 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
628000000 | USD |
| CY2013Q1 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
384000000 | USD |
| CY2014Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
999000000 | USD |
| CY2013Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
568000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-134000000 | USD |
| CY2014Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1000000 | USD |
| CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-53000000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-11000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-81000000 | USD |
| CY2014Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
|
-8000000 | USD |
| CY2013Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
|
-3000000 | USD |
| CY2014Q1 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
-3000000 | USD |
| CY2013Q1 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
-1000000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-5000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-2000000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-32000000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-88000000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-2000000 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.05 | |
| CY2013Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.02 | |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.33 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.85 | |
| CY2014Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.05 | |
| CY2013Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.02 | |
| CY2014Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.33 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.85 | |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
|
-1000000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plan Net Prior Service Cost Credit Arising During Period Before Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
|
0 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
1000000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
0 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
0 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
0 | USD |
| CY2014Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1000000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
0 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-15000000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-83000000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
16000000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
5000000 | USD |
| CY2014Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-31000000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-88000000 | USD |
| CY2014Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-3000000 | USD |
| CY2013Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-55000000 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12000000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-138000000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
557000000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
4000000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
251000000 | USD |
| CY2014Q1 | thc |
Increase Decrease In Inventories And Other Assets Current
IncreaseDecreaseInInventoriesAndOtherAssetsCurrent
|
60000000 | USD |
| CY2013Q1 | thc |
Increase Decrease In Inventories And Other Assets Current
IncreaseDecreaseInInventoriesAndOtherAssetsCurrent
|
44000000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
2000000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-3000000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
29000000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
|
-29000000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11000000 | USD |
| CY2014Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
7000000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5000000 | USD |
| CY2014Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
3000000 | USD |
| CY2013Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
10000000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
13000000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
27000000 | USD |
| CY2014Q1 | thc |
Payments For Restructuring And Litigation Costs
PaymentsForRestructuringAndLitigationCosts
|
30000000 | USD |
| CY2013Q1 | thc |
Payments For Restructuring And Litigation Costs
PaymentsForRestructuringAndLitigationCosts
|
7000000 | USD |
| CY2014Q1 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-14000000 | USD |
| CY2013Q1 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-5000000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-19000000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-32000000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
281000000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
133000000 | USD |
| CY2014Q1 | thc |
Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets
ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets
|
3000000 | USD |
| CY2013Q1 | thc |
Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets
ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets
|
3000000 | USD |
| CY2014Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
0 | USD |
| CY2013Q1 | us-gaap |
Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
|
-2000000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-291000000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-104000000 | USD |
| CY2014Q1 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
665000000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
200000000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
430000000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
220000000 | USD |
| CY2014Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
24000000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
899000000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
600000000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
|
850000000 | USD |
| CY2014Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2013Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
100000000 | USD |
| CY2014Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
11000000 | USD |
| CY2013Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
15000000 | USD |
| CY2014Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
11000000 | USD |
| CY2013Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
6000000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
6000000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
15000000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
0 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
2000000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
338000000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-133000000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
28000000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-269000000 | USD |
| CY2014Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
105000000 | USD |
| CY2013Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
125000000 | USD |
| CY2014Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-1000000 | USD |
| CY2013Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
3000000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
364000000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
95000000 | USD |
| CY2014Q1 | us-gaap |
Loss Contingency Accrual Carrying Value Payments
LossContingencyAccrualCarryingValuePayments
|
9000000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
16000000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
5000000 | USD |
| CY2014Q1 | thc |
Business Combination Acquisition Transaction Related Costs
BusinessCombinationAcquisitionTransactionRelatedCosts
|
6000000 | USD |
| CY2014Q1 | us-gaap |
Health Care Organization Patient Service Revenue Less Provision For Bad Debts
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
3926000000 | USD |
| CY2013Q1 | us-gaap |
Health Care Organization Patient Service Revenue Less Provision For Bad Debts
HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
|
2387000000 | USD |
| CY2013Q1 | us-gaap |
Health Care Organization Revenue
HealthCareOrganizationRevenue
|
2387000000 | USD |
| CY2014Q1 | us-gaap |
Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
|
21000000 | USD |
| CY2014Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
10000000 | USD |
| CY2014Q1 | us-gaap |
Severance Costs1
SeveranceCosts1
|
6000000 | USD |
| CY2014Q1 | thc |
Electronic Health Record Incentives
ElectronicHealthRecordIncentives
|
-9000000 | USD |
| CY2014Q1 | us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
13000000 | USD |
| CY2014Q1 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
3000000 | USD |
| CY2014Q1 | us-gaap |
Other Restructuring Costs
OtherRestructuringCosts
|
5000000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
9000000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
5000000 | USD |
| CY2014Q1 | thc |
Debt Instrument Convenant Secured Debt To Ebitda Ratio
DebtInstrumentConvenantSecuredDebtToEBITDARatio
|
3.00 | pure |
| CY2014Q1 | us-gaap |
Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
|
0.01875 | pure |
| CY2014Q1 | thc |
Debt Instrument Issuance Fee
DebtInstrumentIssuanceFee
|
0.00125 | pure |
